rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Gabriela Gruia

Director

Company insider

Files Form 4 as: Director, Aprea Therapeutics; Director, TScan Therapeutics; Interim Chief Medical Officer, Molecular Templates.

Every Form 4 they filed

In numbers

Trades disclosed
20
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
3
Companies where not an officer
2
First trade
15 Jul 2021
Last trade
16 Jun 2026
Last filed
17 Jun 2026

Companies traded

Where they are an officer
Molecular TemplatesDirector, Officer · last 27 Sep 20240 buys · 0 sells
Everywhere else they filed: board seats, 10% stakes, other companies
APRE Aprea TherapeuticsDirector · Biotechnology · last 16 Jun 20260 buys · 0 sells
TCRX TScan TherapeuticsDirector · Biotechnology · last 20 May 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
16 Jun 2026filed 17 Jun 2026APRE Aprea TherapeuticsBiotechnologySEC FORM 4 Code A—3,135 at $0.00filing
16 Jun 2026filed 17 Jun 2026APRE Aprea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—12,555 at $0.00filing
16 Jun 2026filed 17 Jun 2026APRE Aprea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—12,555 at $0.00filing
16 Jun 2026filed 17 Jun 2026APRE Aprea TherapeuticsBiotechnologySEC FORM 4 Code A—3,135 at $0.00filing
20 May 2026filed 22 May 2026TCRX TScan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—67,000 at $0.00filing
20 May 2026filed 22 May 2026TCRX TScan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—67,000 at $0.00filing
30 Jun 2025filed 2 Jul 2025TCRX TScan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—67,000 at $0.00filing
5 Jun 2025filed 9 Jun 2025APRE Aprea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—4,185 at $0.00filing
5 Jun 2025filed 9 Jun 2025APRE Aprea TherapeuticsBiotechnologySEC FORM 4 Code A—1,045 at $0.00filing
27 Sep 2024filed 30 Sep 2024Molecular Templatesoption or derivativeSEC FORM 4 Code A—1,000 at $0.00filing
12 Jun 2024filed 14 Jun 2024TCRX TScan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—47,500 at $0.00filing
27 Oct 2023filed 31 Oct 2023Molecular Templatesoption or derivativeSEC FORM 4 Code A—1,000 at $0.00filing
31 Aug 2023filed 31 Aug 2023Molecular Templatesoption or derivativeSEC FORM 4 Code A—11,666 at $0.00filing
13 Jun 2023filed 15 Jun 2023TCRX TScan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—35,000 at $0.00filing
5 May 2023filed 8 May 2023APRE Aprea Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—12,500 at $0.00filing
3 Jun 2022filed 6 Jun 2022Molecular Templatesoption or derivativeSEC FORM 4 Code A—15,000 at $0.00filing
1 Jun 2022filed 3 Jun 2022TCRX TScan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—9,146 at $0.00filing
1 Mar 2022filed 2 Mar 2022Molecular Templatesoption or derivativeSEC FORM 4 Code A—25,000 at $0.00filing
15 Jul 2021filed 16 Jul 2021TCRX TScan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—9,146 at $0.00filing
15 Jul 2021filed 16 Jul 2021TCRX TScan Therapeuticsoption or derivative · BiotechnologySEC FORM 4 Code A—9,146 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

Nobody else traded the same names lately.